We spoke to developer of the HEK293 cell line, Frank Graham, about the challenges faced and serendipity required to pioneer a ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results